aTyr Pharma | LIFE - Ebitda

Stock Price
0.89
Daily Change
-0.07 -7.80%
Monthly
18.65%
Yearly
-77.54%
Q1 Forecast
0.86

aTyr Pharma reported $-26.58M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Ardelyx USD 5.57M 17.44M Sep/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 1.96B 1.27B Jun/2025
Galapagos EUR -158.71M 177.84M Mar/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
United Therapeutics USD 436.8M 34.2M Jun/2025